Skip to main content
. 2019 Oct;60(10):1474–1482. doi: 10.2967/jnumed.119.226423

FIGURE 6.

FIGURE 6.

In vivo evaluation of 111In-PA-L1 and 111In-PA-WTK563C in MDA-MB-231 tumor-bearing SCID mice. (A) Blood clearance of 111In-PA-L1 and 111In-PA-WTK563C. (B) Ex vivo biodistribution showing uptake of 111In-PA-L1 or 111In-PA-WTK563C in selected tissues and blood, 3 h after intravenous administration. (C) Tumor-to-blood ratios determined from B. (D and E) Representative coronal and sagittal maximum-intensity projections of SPECT/CT images, 3 h after administration of 111In-PA-L1 or 111In-PA-WTK563C. *P < 0.05. **** P < 0.0001. b = bladder; h = heart; k = kidneys; l = liver; t = tumor.